Kestra

Since March 2024, Ranae LaFerney has contracted with Kestra to write patient stories showcasing the life-saving features of the ASSURE wearable cardioverter defibrillator (WCD). This pioneering medical device has been on the market for less than 3 years and has already documented over 100 lives saved from sudden cardiac arrest. 

Deliverables:

• Ongoing case studies of 800-1000 words each that bring a human perspective to the benefits and efficacy of the ASSURE WCD through real patient experiences.
• Provider and patient brochures for the WCD; press releases (2021-2022).